Renaissance Technologies’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGEN
HF
VF
GWM
LWM
WAM
TRCT
Renaissance Technologies's OGEN Position: Q3 2024 in Review
Renaissance Technologies sold out of Oragenics (OGEN) in Q3 2024, closing a stake of 751 shares — an estimated $23.4K sold.
Renaissance Technologies first reported a position in OGEN in Q4 2017 and held it in 18 quarters. The position peaked at $568K in Q3 2021. 13 funds tracked by Wall St. Rank hold OGEN as of Q3 2024.
- Renaissance Technologies reported no remaining Oragenics position as of Q3 2024 after selling out during the quarter.
- Renaissance Technologies sold 751 Oragenics shares in Q3 2024, an estimated $23.4K.
- Renaissance Technologies first reported a position in Oragenics in Q4 2017 and held it in 18 quarters.
- Renaissance Technologies's Oragenics position peaked at $568K in Q3 2021.
- 13 funds tracked by Wall St. Rank held Oragenics as of Q3 2024.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.